218 related articles for article (PubMed ID: 25052484)
1. Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis.
Wivagg CN; Bhattacharyya RP; Hung DT
J Antibiot (Tokyo); 2014 Sep; 67(9):645-54. PubMed ID: 25052484
[TBL] [Abstract][Full Text] [Related]
2. Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of
Olivença F; Pires D; Silveiro C; Gama B; Holtreman F; Anes E; Catalão MJ
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0158623. PubMed ID: 38411952
[TBL] [Abstract][Full Text] [Related]
3. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Dinçer I; Ergin A; Kocagöz T
Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
[TBL] [Abstract][Full Text] [Related]
4. [
Shi J; Zheng DW; Ma XG; Su RY; Zhu YK; Wang SH; Chang WJ; Sun GQ; Sun DY
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug; 46(8):797-805. PubMed ID: 37536990
[No Abstract] [Full Text] [Related]
5. In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.
Cordillot M; Dubée V; Triboulet S; Dubost L; Marie A; Hugonnet JE; Arthur M; Mainardi JL
Antimicrob Agents Chemother; 2013 Dec; 57(12):5940-5. PubMed ID: 24041897
[TBL] [Abstract][Full Text] [Related]
6. Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing.
Olivença F; Nunes A; Macedo R; Pires D; Silveiro C; Anes E; Miragaia M; Gomes JP; Catalão MJ
Microbiol Spectr; 2022 Aug; 10(4):e0067422. PubMed ID: 35695524
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality Approach.
Xiao S; Guo H; Weiner WS; Maddox C; Mao C; Gunosewoyo H; Pelly S; White EL; Rasmussen L; Schoenen FJ; Aubé J; Bishai WR; Lun S
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427291
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis and beta-lactam antibiotics.
Gun MA; Bozdogan B; Coban AY
Future Microbiol; 2020 Jul; 15():937-944. PubMed ID: 32762449
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Zhang D; Wang Y; Lu J; Pang Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):393-9. PubMed ID: 26525785
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
Flores AR; Parsons LM; Pavelka MS
Microbiology (Reading); 2005 Feb; 151(Pt 2):521-532. PubMed ID: 15699201
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.
Solapure S; Dinesh N; Shandil R; Ramachandran V; Sharma S; Bhattacharjee D; Ganguly S; Reddy J; Ahuja V; Panduga V; Parab M; Vishwas KG; Kumar N; Balganesh M; Balasubramanian V
Antimicrob Agents Chemother; 2013 Jun; 57(6):2506-10. PubMed ID: 23507276
[TBL] [Abstract][Full Text] [Related]
12. Collateral Sensitivity to β-Lactam Drugs in Drug-Resistant Tuberculosis Is Driven by the Transcriptional Wiring of BlaI Operon Genes.
Trigos AS; Goudey BW; Bedő J; Conway TC; Faux NG; Wyres KL
mSphere; 2021 Jun; 6(3):e0024521. PubMed ID: 34047652
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.
Cohen KA; El-Hay T; Wyres KL; Weissbrod O; Munsamy V; Yanover C; Aharonov R; Shaham O; Conway TC; Goldschmidt Y; Bishai WR; Pym AS
EBioMedicine; 2016 Jul; 9():170-179. PubMed ID: 27333036
[TBL] [Abstract][Full Text] [Related]
14. Synthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactams.
Lun S; Miranda D; Kubler A; Guo H; Maiga MC; Winglee K; Pelly S; Bishai WR
mBio; 2014 Sep; 5(5):e01767-14. PubMed ID: 25227469
[TBL] [Abstract][Full Text] [Related]
15. Reappraising the use of β-lactams to treat tuberculosis.
Kurz SG; Bonomo RA
Expert Rev Anti Infect Ther; 2012 Sep; 10(9):999-1006. PubMed ID: 23106275
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
Wang F; Cassidy C; Sacchettini JC
Antimicrob Agents Chemother; 2006 Aug; 50(8):2762-71. PubMed ID: 16870770
[TBL] [Abstract][Full Text] [Related]
17. [Efficient combination of clavulanate and beta-lactam antibiotics against extensively drug-resistant M. tuberculosis].
Hugonnet JE
Med Sci (Paris); 2009; 25(8-9):661-3. PubMed ID: 19765373
[No Abstract] [Full Text] [Related]
18. Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.
Kumar P; Kaushik A; Bell DT; Chauhan V; Xia F; Stevens RL; Lamichhane G
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069655
[TBL] [Abstract][Full Text] [Related]
19. Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Segura C; Salvadó M; Collado I; Chaves J; Coira A
Antimicrob Agents Chemother; 1998 Jun; 42(6):1524-6. PubMed ID: 9624510
[TBL] [Abstract][Full Text] [Related]
20. Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.
Viswanathan G; Yadav S; Raghunand TR
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]